What STDcheck does

STDcheck.com is a Houston-based direct-to-consumer online STD testing service founded in 2010 by CEO Fiyyaz Pirani, operating as a subsidiary of Analyte Health under the legal entity FPK Services, LLC. The platform enables customers to order FDA-approved and cleared diagnostic tests online or by phone, visit any of 4,500+ CLIA-certified laboratory testing centers nationwide for sample collection, and receive confidential results within 1-2 days via a secure online account. Its catalog spans individual tests priced from $24 (Chlamydia, Gonorrhea, Hepatitis A/B/C, Herpes I & II, HIV antibody, Syphilis, Trichomoniasis, Mycoplasma Genitalium) up to a 10-Test Panel at $349 that includes the only FDA-approved HIV RNA Early Detection Test on the market, plus an extended 13-Test Panel with wellness screenings. The company refuses insurance billing to preserve privacy, supports payment via HSA/FSA and modern wallets, and offers free physician consultation with treatment prescription for positive results.

The business model is primarily transactional one-time test sales to consumers, supplemented by a 40% commission affiliate program through CJ Affiliate by Conversant, a B2B white-label partner program, and nonprofit/educational institute outreach programs that delivered 130,000+ tests in 2021. Customer segments include sexually active adults (primary), minors aged 16-17 served without parental consent, the LGBT community, and college students reached through programs such as the HIV-Positive Scholarship. The company has served over 2 million customers since founding, maintains a 9.8/10 rating across 5,236 reviews, and is BBB accredited, HIPAA-compliant, and FDA/CLIA-aligned, with no external funding rounds disclosed in the available sources.

Name

STDcheck

Legal name

FPK Services, LLC

Website

https://stdcheck.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

STDcheck.com is a Houston-based direct-to-consumer online STD testing service that lets customers order FDA-approved tests online, visit 4,500+ CLIA-certified labs nationwide, and receive confidential results in 1-2 days. A subsidiary of Analyte Health, it has served over 2 million customers since 2010.

Ownership category

akta.pro rank

Product category

Direct-to-Consumer STD Testing Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK)

akta.pro secondary industry

Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

Keywords

• Online STD testing
• Sexual health screening
• CLIA-certified lab diagnostics
• Confidential lab testing
• Direct-to-consumer diagnostics

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Marketing or Sales, Operations, Personnel, Technology or R&D, Others

Revenue model

1. Direct Test Sales: One-time purchase of individual STD tests or panel packages. Customers pay upfront for testing services rendered at partner laboratory locations. Prices range from $24 for individual tests to $349 for comprehensive 10-Test Panel with HIV RNA Early Detection. Additional revenue from medical consultations for positive results.
2. Affiliate Program: 40% commission on all referred customer purchases through CJ Affiliate by Conversant network. Affiliates receive recurring commissions from customer referrals who purchase within 45-day window.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

STDcheck sells FDA-approved/cleared STD tests directly to consumers through its website and phone ordering. Customers order tests online, visit one of 4,500+ CLIA-certified testing centers for sample collection, and receive confidential results via a secure online portal within 1-2 days. The offering includes individual tests for specific infections and comprehensive 10-Test and 13-Test Panels, with free physician consultation and treatment prescriptions for positive results.

Product overview

STDcheck is an online STD testing platform offering FDA-approved/cleared diagnostic tests through a network of over 4,500 CLIA-certified testing centers nationwide. The core product is the online test ordering and results delivery service, available as comprehensive test panels (10-Test Panel, 13-Test Panel with wellness tests) or individual tests for specific infections including Chlamydia, Gonorrhea, Hepatitis A/B/C, Herpes I & II, HIV (antibody and RNA early detection), Syphilis, Trichomoniasis, and Mycoplasma Genitalium. The platform includes supplementary services such as physician consultation for positive results, an STD Test Recommender tool, and a B2B partner program for white-label services. Results are delivered within 1-2 days via secure online account. The company was founded in 2010 and has served over 2 million customers.

Differentiator

Problem solved

Functional benefit

Products and services

• 10-Test Panel Comprehensive 10-disease STD screening panel including HIV-1, HIV-2, gonorrhea, chlamydia, syphilis, herpes 1 & 2, and hepatitis A, B, and C, priced at $349 with HIV RNA Early Detection included. Aimed at sexually active adults seeking a single comprehensive evaluation.
• 13-Test Panel Most comprehensive screening panel covering 10 STDs plus Trichomoniasis, Mycoplasma Genitalium, and wellness tests, designed for broader coverage including HIV 1 & 2 (4th Gen), syphilis, gonorrhea, chlamydia, hepatitis A, B, C, trichomoniasis, mycoplasma genitalium, and herpes 1 & 2.
• Chlamydia & Gonorrhea Panel Joint panel test for Chlamydia and Gonorrhea infections using FDA-approved/cleared methodology.
• Herpes I & II Test Combined testing for oral herpes (HSV-1) and genital herpes (HSV-2) infections.
• HIV 1 & 2 Antibody (4th Gen) Test FDA-cleared 4th generation HIV-1 and HIV-2 antibody test for standard-window HIV screening.
• HIV RNA Early Detection Test Only FDA-approved HIV RNA Early Detection Test on the market. Detects HIV genetic material 9-11 days after exposure, earlier than antibody-based tests that require 30+ days.
• Chlamydia Test Individual FDA-approved/cleared test for Chlamydia infection, available starting at $24.
• Gonorrhea Test Individual FDA-approved/cleared test for Gonorrhea infection.
• Hepatitis A Test Individual FDA-approved/cleared test for Hepatitis A infection.
• Hepatitis B Test Individual FDA-approved/cleared test for Hepatitis B infection.
• Hepatitis C Test Individual FDA-approved/cleared test for Hepatitis C infection.
• Oral Herpes Test Individual FDA-approved/cleared test for oral herpes (HSV-1) infection.
• Genital Herpes Test Individual FDA-approved/cleared test for genital herpes (HSV-2) infection.
• Syphilis Test Individual FDA-approved/cleared test for Syphilis infection.
• Trichomoniasis Test Individual FDA-approved/cleared test for Trichomoniasis infection.
• Mycoplasma Genitalium Test Individual FDA-approved/cleared test for Mycoplasma Genitalium infection.
• Doctor Consultation Free physician consultation service for patients who test positive, with licensed doctors reviewing results and able to prescribe treatment for the patient and partner.

Quantifiable outcome

• Results delivered in 1-2 days vs 1-2 weeks at free clinics
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered minor and core.

• Nonprofits and Educational InstitutesminorStrategic or Co-development Partner · 1 January 2022Partnerships with various nonprofits and educational institutes for STD testing programs. Testing over 130,000 people for genital herpes in 2021 through these partnerships.
• LabCorpcoreTechnology or IntegrationLaboratory testing partner for STD testing services. CLIA-certified lab processing patient samples collected at testing centers.
• Quest DiagnosticscoreTechnology or IntegrationLaboratory testing partner for STD testing services. CLIA-certified lab processing patient samples collected at testing centers.
• CJ Affiliate by Conversant (Commission Junction)coreChannel Partner/ Reseller/ DistributorAffiliate marketing network managing partner relationships and commission tracking. STDcheck offers 40% commission on referred sales with 45-day cookie tracking through this network.
• Analyte HealthcoreOthersParent company of STDcheck.com. STDcheck is a subsidiary of Analyte Health, which also operates Healthlabs.com, PaternityLabs.com, and UTITreatment.com sister sites.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Ro: Direct-to-consumer healthcare company offering telehealth, pharmacy, and at-home lab testing across multiple categories. Comparable patient-facing confidential health platform with significant capital backing, competing for the same DTC health consumer.
• Quest Diagnostics: One of the two largest clinical laboratory companies in the US and an existing STDcheck lab partner. QuestDirect consumer offering directly competes with STDcheck while also powering its backend, creating both partnership and competitive tension.
• Labcorp: One of the two largest clinical laboratory companies in the US and an existing STDcheck lab partner. Labcorp OnDemand consumer offering competes with STDcheck while also serving as its core processing infrastructure.
• Hims & Hers Health: Large direct-to-consumer telehealth platform offering sexual health, hair loss, skincare, and primary care services. Comparable direct-to-consumer confidential care model for sensitive health categories, with significantly broader scope and brand recognition.

Direct peers

• Nurx: Telehealth platform specializing in sexual and reproductive health including STD testing, PrEP, and birth control. Comparable confidential, direct-to-consumer care model for sexual health needs, though with stronger emphasis on telehealth consultations.
• LetsGetChecked: Direct-to-consumer at-home diagnostic testing platform offering sexual health tests among many other categories. Competes with STDcheck on confidential testing with home sample collection and telehealth follow-up.
• Health Testing Centers: Direct-to-consumer online lab testing service offering confidential STD and other health tests through partner labs. Closely mirrors STDcheck's online ordering, lab center visit, and fast result delivery model.
• myLAB Box: At-home STD testing company offering FDA-cleared test kits shipped directly to consumers. Most direct competitor to STDcheck specifically focused on sexual health testing, with comparable pricing and confidentiality positioning.
• Everlywell: Direct-to-consumer lab testing platform offering at-home test collection kits across multiple categories including sexual health. Closely comparable to STDcheck in offering FDA-cleared tests marketed directly to consumers with online ordering and physician-reviewed results.
• Priority STD: Direct-to-consumer STD testing service using partner lab network, closely mirroring STDcheck's model of confidential online ordering with lab center visits for sample collection and fast result delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/STDcheck
• Xx.com/stdcheck
• LinkedInlinkedin.com/company/std-check

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STDcheck